Tenaya Therapeutics, Inc.
TNYA
$0.4912
$0.03066.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.96M | 6.36M | 8.17M | 8.71M | 8.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.65M | 26.71M | 30.82M | 33.76M | 31.45M |
| Operating Income | -24.65M | -26.71M | -30.82M | -33.76M | -31.45M |
| Income Before Tax | -23.84M | -25.63M | -29.43M | -32.23M | -29.94M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.84M | -25.63M | -29.43M | -32.23M | -29.94M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.84M | -25.63M | -29.43M | -32.23M | -29.94M |
| EBIT | -24.65M | -26.71M | -30.82M | -33.76M | -31.45M |
| EBITDA | -22.56M | -24.61M | -28.70M | -31.61M | -29.27M |
| EPS Basic | -0.28 | -0.30 | -0.34 | -0.40 | -0.40 |
| Normalized Basic EPS | -0.17 | -0.19 | -0.21 | -0.25 | -0.25 |
| EPS Diluted | -0.28 | -0.30 | -0.34 | -0.40 | -0.40 |
| Normalized Diluted EPS | -0.17 | -0.19 | -0.21 | -0.25 | -0.25 |
| Average Basic Shares Outstanding | 86.41M | 86.16M | 85.71M | 80.98M | 74.10M |
| Average Diluted Shares Outstanding | 86.41M | 86.16M | 85.71M | 80.98M | 74.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |